kras g12c inhibition in advanced nsclc: amg 510
Published 4 years ago • 271 plays • Length 4:09Download video MP4
Download video MP3
Similar videos
-
7:51
kras g12c inhibition in advanced nsclc: amg 510
-
2:20
kras g12c inhibition in advanced nsclc: mrtx849
-
2:53
kras g12c inhibition in advanced nsclc: mrtx849
-
5:23
kras g12c inhibitors: acquired resistance and combo strategies
-
2:38
key lung cancer updates: kras(g12c) inhibitors and adcs
-
4:44
practical considerations for amg 510 in kras-mutant nsclc
-
5:29
development of kras g12c-targeted therapy in nsclc
-
1:37
expert discusses kras g12c inhibitors for patients with nsclc
-
3:41
amg 510 kras inhibitor trial results – ‘a good start’ | colin lindsay
-
2:49
targeted therapy for kras p.g12c nsclc
-
1:59
molecular determinants of kras g12c inhibitor efficacy in advanced nsclc
-
1:12
overcoming resistance to kras g12c inhibitors in nsclc
-
1:08
dr. fakih on the safety profile of amg 510 in kras g12c-mutated crc
-
0:47
the role of immunotherapy with kras inhibitors in kras-driven nsclc
-
0:50
kras g12c emerges as new potential target in non-small cell lung cancer
-
2:09
esmo highlights: kras g12c inhibitors
-
10:34
the potential of kras inhibitors for non-small-cell lung cancer
-
1:26
krystal-1 and codebreak 100: targeting kras g12c in lung cancer
-
1:50
dr. parikh on kras inhibitors in lung cancer